Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Yi Chuan = Hereditas|July 26, 2007
[Advanced study on SERK genes family]Qing-Guang Lin, Bai-Ming Cui, Ming PengThe British Journal of Radiology|February 6, 2018
Ultrasound elastography as an imaging biomarker for detection of early tumor response to chemotherapy in a murine breast cancer model: a feasibility studyJian-Wei Wang, Zhi-Xing Guo, Qing-Guang Lin, et al.Academic Radiology|December 20, 2025
Glandular Tissue Component on Breast Ultrasound: Association with Survival Outcomes in Women with Invasive Breast CancerTing-Ting Deng, Cui-Ju Yan, Qing-Guang Lin, et al.Aging|January 23, 2020
Development of prognostic index based on autophagy-related genes analysis in breast cancerQing-Guang Lin, Wei Liu, Yu-Zhen Mo, et al.Ultrasound in Medicine & Biology|July 27, 2015
Quantitative Contrast-Enhanced Ultrasonic Imaging Reflects Microvascularization in Hepatocellular Carcinoma and Prognosis after ResectionRu-Hai Zou, Qing-Guang Lin, Wei Huang, et al.European Radiology|December 1, 2017
Efficacy of ultrasound-guided core needle biopsy in cervical lymphadenopathy: A retrospective study of 6,695 casesFeng Han, Min Xu, Ting Xie, et al.Science Advances|February 4, 2021
Laminin γ2-mediating T cell exclusion attenuates response to anti-PD-1 therapyLei Li, Jia-Ru Wei, Jun Dong, et al.The Laryngoscope|December 30, 2020
Transoral Robotic Retropharyngeal Lymph Node Dissection in Nasopharyngeal Carcinoma With Retropharyngeal Lymph Node RecurrenceXi Ding, Qing-Guang Lin, Xiong Zou, et al.European Journal of Nuclear Medicine and Molecular Imaging|October 27, 2022
Benefit of [<sup>18</sup>F] FDG PET/CT in the diagnosis and salvage treatment of recurrent nasopharyngeal carcinomaPu-Yun OuYang, Zhi-Qiao Liu, Qing-Guang Lin, et al.Lancet (London, England)|June 2, 2024
Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trialXu Liu, Yuan Zhang, Kun-Yu Yang, et al.Pageof 2